-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
المؤلفون: Callaghan AW, Chard AN, Arnold P, Loveland C, Hull N, Saraiya M, Saydah S, Dumont W, Frakes LG, Johnson D, Peltier R, Van Houten C, Trujillo AA, Moore J, Rose DA, Honein MA, Carrington D, Harrist A, Hills SL
المصدر: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2020 Jul 03; Vol. 69 (26), pp. 825-829. Date of Electronic Publication: 2020 Jul 03.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE
مواضيع طبية MeSH: Hospitals, Psychiatric* , Mass Screening* , Residential Facilities*, Coronavirus Infections/*prevention & control , Cross Infection/*prevention & control , Pandemics/*prevention & control , Pneumonia, Viral/*prevention & control, Adult ; Aged ; COVID-19 ; Coronavirus Infections/epidemiology ; Coronavirus Infections/transmission ; Cross Infection/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/transmission ; Wyoming/epidemiology
-
4دورية أكاديمية
المؤلفون: Di H; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA; Oak Ridge Institute for Science and Education, P.O. Box 117, Oak Ridge, TN, 37831, USA., Thor SW; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA., Trujillo AA; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA., Stark TJ; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA., Marinova-Petkova A; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA., Jones J; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA., Wentworth DE; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA., Barnes JR; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA., Davis CT; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA. Electronic address: ctdavis@cdc.gov.
المصدر: Journal of virological methods [J Virol Methods] 2019 Aug; Vol. 270, pp. 95-105. Date of Electronic Publication: 2019 Apr 18.
نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 8005839 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0984 (Electronic) Linking ISSN: 01660934 NLM ISO Abbreviation: J Virol Methods Subsets: MEDLINE
-
5دورية أكاديمية
المؤلفون: Hardy MC; Laboratory Leadership Service Fellowship, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.; Division of Foodborne and Waterborne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.; Office of the Chief Regulatory Scientist, Australian Pesticides and Veterinary Medicines Authority, Armidale, New South Wales, 2350, Australia., Stinnett RC; Laboratory Leadership Service Fellowship, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Kines KJ; Laboratory Leadership Service Fellowship, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.; Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.; Office of the Deputy Director for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Rivera-Nazario DM; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.; Office of the Deputy Director for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Lowe DE; Laboratory Leadership Service Fellowship, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Mercante AM; Division of Foodborne and Waterborne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Gonzalez Jimenez N; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Cuevas Ruiz RI; Public Health Laboratories, Puerto Rico Department of Health, San Juan, PR, 00936, USA., Rivera Arbolay HI; Public Health Laboratories, Puerto Rico Department of Health, San Juan, PR, 00936, USA., Gonzalez Peña RL; Public Health Laboratories, Puerto Rico Department of Health, San Juan, PR, 00936, USA., Toro M; Public Health Laboratories, Puerto Rico Department of Health, San Juan, PR, 00936, USA., Trujillo AA; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Pappas CL; Influenza Division, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Llewellyn AC; Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Candal F; Office of Technology and Innovation, Office of Science, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Burgos Garay M; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Gomez GA; Division of Foodborne and Waterborne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Concepcion Acevedo J; Division of Foodborne and Waterborne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Ansbro M; Division of Select Agents and Toxins, Center for Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Moura H; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Shaw MW; Office of the Deputy Director for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Muehlenbachs A; Office of the Deputy Director for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Romanoff LC; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Sunshine BJ; Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Rose DA; Division of Emergency Operations, Center for Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, Georgia, 30329, USA.; Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Patel A; Influenza Coordination Unit, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Shapiro CN; Division of Emergency Operations, Center for Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, Georgia, 30329, USA., Luna-Pinto SC; Office of the Director, Center for State, Tribal, Local and Territorial Support, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., Pillai SK; Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA., O'Neill E; Office of the Deputy Director for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA. eoneill@cdc.gov.
المصدر: Nature communications [Nat Commun] 2019 Jun 20; Vol. 10 (1), pp. 2720. Date of Electronic Publication: 2019 Jun 20.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: PubMed not MEDLINE
-
6دورية أكاديمية
المؤلفون: Nguyen HT; Influenza Division, Centers for Disease Control and Prevention, Mail Stop G-16, 1600 Clifton Road, Atlanta, GA 30333, USA., Trujillo AA, Sheu TG, Levine M, Mishin VP, Shaw M, Ades EW, Klimov AI, Fry AM, Gubareva LV
المصدر: Antiviral research [Antiviral Res] 2012 Mar; Vol. 93 (3), pp. 381-6. Date of Electronic Publication: 2012 Feb 07.
نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE
مواضيع طبية MeSH: Drug Resistance, Viral*, Antiviral Agents/*pharmacology , Influenza A Virus, H1N1 Subtype/*isolation & purification , Influenza, Human/*virology , Oseltamivir/*pharmacology, Animals ; Cell Line ; Humans ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/enzymology ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza, Human/epidemiology ; Mutation, Missense ; Neuraminidase/genetics ; Neuraminidase/metabolism ; Pandemics ; United States/epidemiology ; Viral Proteins/genetics ; Viral Proteins/metabolism
-
7دورية أكاديمية
المؤلفون: Deyde VM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta Georgia 30333, USA., Sheu TG, Trujillo AA, Okomo-Adhiambo M, Garten R, Klimov AI, Gubareva LV
المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2010 Mar; Vol. 54 (3), pp. 1102-10. Date of Electronic Publication: 2009 Dec 22.
نوع المنشور: Evaluation Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
مواضيع طبية MeSH: Genetic Markers*, Antiviral Agents/*pharmacology , Drug Resistance, Viral/*genetics , Influenza A Virus, H1N1 Subtype/*drug effects , Oseltamivir/*pharmacology , Reverse Transcriptase Polymerase Chain Reaction/*methods, Amino Acid Sequence ; Humans ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza, Human/virology ; Molecular Sequence Data ; Neuraminidase/genetics ; Sensitivity and Specificity ; Sequence Analysis, DNA/methods ; Viral Matrix Proteins/genetics ; Viral Proteins/genetics
-
8دورية أكاديمية
المؤلفون: Gubareva LV; Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. lgubareva@cdc.gov., Trujillo AA, Okomo-Adhiambo M, Mishin VP, Deyde VM, Sleeman K, Nguyen HT, Sheu TG, Garten RJ, Shaw MW, Fry AM, Klimov AI
المصدر: Antiviral therapy [Antivir Ther] 2010; Vol. 15 (8), pp. 1151-9.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print Cited Medium: Internet ISSN: 2040-2058 (Electronic) Linking ISSN: 13596535 NLM ISO Abbreviation: Antivir Ther Subsets: MEDLINE
مواضيع طبية MeSH: Adamantane/*pharmacology , Antiviral Agents/*pharmacology , Enzyme Inhibitors/*pharmacology , Influenza A Virus, H1N1 Subtype/*drug effects , Neuraminidase/*antagonists & inhibitors, Acids, Carbocyclic ; Amino Acid Substitution ; Animals ; Cell Line ; Cyclopentanes/pharmacology ; Dogs ; Drug Resistance, Viral/genetics ; Guanidines/pharmacology ; Humans ; Influenza A Virus, H1N1 Subtype/growth & development ; Influenza A Virus, H1N1 Subtype/physiology ; Influenza, Human/drug therapy ; Influenza, Human/virology ; Microbial Sensitivity Tests ; Mutation, Missense ; Neuraminidase/genetics ; Oseltamivir/pharmacology ; Pyrans ; Pyrrolidines/pharmacology ; Sialic Acids ; Viral Plaque Assay ; Zanamivir/analogs & derivatives ; Zanamivir/pharmacology
-
9دورية أكاديمية
المؤلفون: Carvalho Mda G; Respiratory Diseases Branch, Centers for Disease Control & Prevention, Atlanta, Georgia 30333, USA., Pimenta FC, Gertz RE Jr, Joshi HH, Trujillo AA, Keys LE, Findley J, Moura IS, Park IH, Hollingshead SK, Pilishvili T, Whitney CG, Nahm MH, Beall BW
مؤلفون مشاركون: Active Bacterial Core Surveillance Team
المصدر: Journal of clinical microbiology [J Clin Microbiol] 2009 Mar; Vol. 47 (3), pp. 554-9. Date of Electronic Publication: 2008 Dec 30.
نوع المنشور: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 7505564 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-660X (Electronic) Linking ISSN: 00951137 NLM ISO Abbreviation: J Clin Microbiol Subsets: MEDLINE
مواضيع طبية MeSH: Bacterial Typing Techniques*, DNA, Bacterial/*genetics , Pneumococcal Infections/*microbiology , Polymerase Chain Reaction/*methods , Streptococcus pneumoniae/*classification , Streptococcus pneumoniae/*genetics, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Genotype ; Humans ; Incidence ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Molecular Epidemiology ; Penicillin Resistance ; Pneumococcal Infections/epidemiology ; Serotyping ; Streptococcus pneumoniae/isolation & purification ; United States/epidemiology ; Young Adult